Umbrella for the suite of valuation adjustments applied to OTC derivative prices: CVA (counterparty credit), DVA (own credit), FVA (funding cost of uncollateralised exposure beyond OIS), ColVA (collateral mismatch), KVA (regulatory capital), MVA (initial-margin funding). Each XVA is, at heart, a discounted integral of an expected exposure (EPE or ENE) against a specific 'cost rate' (CDS hazard, funding spread, capital cost, margin funding cost). Aggregated additively into the trade price, though double-counting between FVA and DVA remains theoretically contested (Hull-White vs Burgard-Kjaer).